Research | OneLook Acronym Finder |
Serial Number | 87816240 |
Registration Number | 5846370 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Novartis Pharmaceuticals Corporation |
Attorney Name | Maury M. Tepper, III |
Law Office Assigned | L30 |
Employee Name | RICHARDS, SUSAN ANN |
2018-03-01 | Application Filed |
2018-08-07 | Published for Opposition |
2019-03-27 | Date of First Use |
2019-07-24 | Location: PUBLICATION AND ISSUE SECTION |
2019-08-27 | Status: Live/Registered |
2019-08-27 | Trademark Registered |
2019-08-27 | Transaction Date |
Owner: | Novartis AG |
Address | CH-4002 Basel CH 4002 |
Legal Entity Type | Corporation |
Legal Entity State | CH |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the central nervous system, the immune system, the metabolic system and the musculo-skeletal system; pharmaceutical preparations for the treatment of inflammatory disorders and pain; pharmaceutical preparations for the prevention and treatment of hormonal deficiency and metabolic disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders |
GS0051 | Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the central nervous system, the immune system, the metabolic system and the musculo-skeletal system; pharmaceutical preparations for the treatment of inflammatory disorders and pain; pharmaceutical preparations for the prevention and treatment of hormonal deficiency and metabolic disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2018-03-05 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-03-08 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2018-06-08 | 3 DOCK D:Assigned to Examiner |
EXAMINERS AMENDMENT -WRITTEN | 2018-06-19 | 4 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2018-06-19 | 5 GNEA F:First Action |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-06-19 | 6 GNEN O:Outgoing Correspondence |
ASSIGNED TO LIE | 2018-06-19 | 7 ALIE A:Allowance for Publication |
EXAMINER'S AMENDMENT ENTERED | 2018-06-19 | 8 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-06-29 | 9 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-07-18 | 10 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2018-08-07 | 11 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-08-07 | 12 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-10-02 | 13 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-04-01 | 14 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2019-04-01 | 15 EXT1 S: |
EXTENSION 1 GRANTED | 2019-04-01 | 16 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-04-03 | 17 EXRA E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2019-06-25 | 18 EISU I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-07-16 | 19 AITU A:Allowance for Publication |
USE AMENDMENT FILED | 2019-06-25 | 20 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2019-07-16 | 21 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-07-24 | 22 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-07-25 | 23 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2019-08-27 | 24 R.PR A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.